QuanterixQTRX -0.35%58 Market Cap is $203.3 Mil as of Jul. 05, 2026. GuruFocus rates QTRX with a GF Score™ of 58/100 and a GF Value™ of $11.67 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 868 Medical Devices & Instruments companies, Quanterix ranks better than 56.34% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Quanterix's share price for the quarter that ended in Mar. 2026 was $3.52. Quanterix's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 47.1 Mil. Therefore, Quanterix's market cap for the quarter that ended in Mar. 2026 was $165.7 Mil.
Quanterix's quarterly market cap
increased
from Sep. 2025 ($253.5 Mil) to Dec. 2025 ($297.3 Mil) but then
declined
from Dec. 2025 ($297.3 Mil) to Mar. 2026 ($165.7 Mil).
Quanterix's annual market cap
declined
from Dec. 2023 ($1,039.3 Mil) to Dec. 2024 ($409.7 Mil) and
declined
from Dec. 2024 ($409.7 Mil) to Dec. 2025 ($297.3 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Quanterix's Enterprise Value for Today is $139.3 Mil.
Quanterix (NAS:QTRX) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Quanterix Market Cap Related Terms
Quanterix Market Cap Historical Data
* Premium members only.
The historical data trend for Quanterix's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Quanterix's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quanterix Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Quanterix's Market Cap distribution charts can be found below:
* The bar in red indicates where Quanterix's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Quanterix's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Quanterix (QTRX) has a Market Cap of $203.3 Mil as of Jul. 05, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Quanterix and its competitors. According to the industry distribution chart, Quanterix ranks #379 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 43.7%.
Is Quanterix's Market Cap too high?
Quanterix's current Market Cap is $203.3 Mil. The Medical Devices & Instruments industry median Market Cap is 120.30. Quanterix's value of $203.3 Mil is 69% above this industry median. Based on the distribution chart, Quanterix ranks #379 out of 868 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Quanterix has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Quanterix's Market Cap compare to LUCD and INFU?
According to the Medical Devices & Instruments industry distribution chart, Quanterix ranks #379 out of 868 companies for Market Cap. This puts Quanterix in the upper half of its industry. The industry median Market Cap is 120.30. Quanterix's value of $203.3 Mil is 69% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 120.30, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Quanterix's current Market Cap of $203.3 Mil is 69% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Quanterix and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 120.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quanterix's current Market Cap is $203.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quanterix stock overvalued right now?
Based on GuruFocus' analysis, Quanterix (QTRX) is currently considered Possible Value Trap. The stock's GF Value™ is $11.67, compared to a current price of $4.32 — trading 63% below its estimated fair value. The current Market Cap is $203.3 Mil and 69% above the Medical Devices & Instruments industry median of 120.30. Quanterix's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Quanterix (QTRX), the current Market Cap is $203.3 Mil as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Quanterix (QTRX) Overvalued in 2026?
Based on GuruFocus' analysis, Quanterix stock appears to be undervalued.
The current stock price of $4.32 is trading 63% below its estimated GF Value™ of $11.67.
GuruFocus considers Quanterix to be Possible Value Trap.
Key valuation signals for QTRX:
Market Cap: $203.3 Mil
GF Value™: $11.67 vs. price of $4.32 (63% below fair value)
Industry Position: 69% above the Medical Devices & Instruments median (#379 of 868)
No single metric tells the full story. See the QTRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.
58GF Score
Get the complete analysis for QTRX
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
QTRX has been successfully added to your 
